Results 211 to 220 of about 125,477 (319)

The sites of phosphorylation by protein kinase C and an intact SH2 domain are required for the enhanced response to beta-adrenergic agonists in cells overexpressing c-src

Molecular and Cellular Biology, 1993
J. Moyers, A. Bouton, S. Parsons
semanticscholar   +1 more source

Drug Interactions With Excessive Daytime Sleepiness Treatments. [PDF]

J Pharm Technol
Thomas SV, Malesker MA, Hilleman DE, Dewan NA.   +3 more
europepmc   +1 more source

Faculty Opinions recommendation of Combination of roflumilast with a beta-2 adrenergic receptor agonist inhibits proinflammatory and profibrotic mediator release from human lung fibroblasts.

, 2012
Hajime Takizawa, Tetsu Kobayashi
openalex   +2 more sources

Thermogenic Targets for Obesity Management in the Era of Incretin-Based Therapies. [PDF]

Pharmaceuticals (Basel)
Soliman S, Andrews-Dickert R, Rocic P, Mitov M.   +3 more
europepmc   +1 more source

The beta-adrenergic receptor survives solubilization in deoxycholate while forming a stable association with the agonist.

, 1984
Elly Nedivi, M. Schramm
openalex   +1 more source

Inadvertent Salbutamol Overdose Presenting as Acute Toxicity. [PDF]

Cureus
Aslam SM, Shyllesh H A, Siddarth Ts V, Suhail K M, Kulkarni A.   +4 more
europepmc   +1 more source

Impact of physical and psychological stressors on tumor growth and immune responses in breast cancer. [PDF]

Compr Psychoneuroendocrinol
Dees K, Kabir K, Bahani R, Beskow C, Blalock M, Burton E, Kranzlein J, Pierson D, Rice S, Williams M, Dugger KJ.   +10 more
europepmc   +1 more source

Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent .beta.-adrenergic agonist virtually specific for .beta.3 receptors. A promising antidiabetic and antiobesity agent

, 1992
Jonathan D. Bloom, Minu Dutia, Bernard D. Johnson, Allan Wissner, Michael Burns, Elwood Largis, Jo Alene Dolan, Thomas H. Claus   +7 more
openalex   +1 more source

Implication of Central β₂ Adrenergic Receptor for the Development of Novel Drugs Against Alzheimer's Disease. [PDF]

Arch Pharm (Weinheim)
Wang A, Since M, Dallemagne P, Rochais C.   +3 more
europepmc   +1 more source

Beta-adrenergic agonists that down-regulate receptor mRNA up-regulate a M(r) 35,000 protein(s) that selectively binds to beta-adrenergic receptor mRNAs.

, 1992
J. David Port, Liliang Huang, C C Malbon
openalex   +1 more source